热景生物股价涨5.05%，景顺长城基金旗下1只基金重仓，持有17.85万股浮盈赚取132.99万元

Group 1 - The core viewpoint of the news is that Beijing Hotgen Biotech Co., Ltd. has seen a stock price increase of 5.05%, reaching 154.89 yuan per share, with a total market capitalization of 14.36 billion yuan [1] - The company specializes in the research, development, production, and sales of in vitro diagnostic reagents and instruments, with its main business revenue composition being 70.87% from testing reagents, 19.79% from testing instruments, 8.17% from others, and 1.17% from biological raw materials [1] - The stock trading volume for the day was 2.70 billion yuan, with a turnover rate of 1.92% [1] Group 2 - In terms of fund holdings, Invesco Great Wall Fund has a significant position in Hotgen Biotech, with its fund "Invesco Great Wall Emerging Industries Mixed A" holding 178,500 shares, accounting for 3.7% of the fund's net value, ranking as the tenth largest holding [2] - The fund has a total scale of 487 million yuan and has achieved a year-to-date return of 2.75%, ranking 6142 out of 8861 in its category [2] - The fund manager, Nong Bingli, has been in position for 7 years and 222 days, with the best fund return during his tenure being 174.01% [3]